Gastrointestinal tract colonization with vancomycin-resistant Enterococcus faecium in an animal model

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 6, 1996, Pages 1526-1530

  Whitman, Marc S ^a   Pitsakis, Peter G ^a   DeJesus, Edwin ^a   Osborne, Arthur J ^a   Levison, Matthew E ^a   Johnson, Caroline C ^a,b  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RAMOPLANIN; STREPTOMYCIN; VANCOMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL COLONIZATION; DRUG EFFICACY; ENTEROCOCCUS FAECALIS; FEMALE; GASTROINTESTINAL INFECTION; GROWTH INHIBITION; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; STREPTOCOCCUS INFECTION;

EID: 0029924918     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.6.1526     Document Type: Article

References (27)

1. Bartoloni, A., M. G. Colao, A. Orsi, R. Dei, E. Giganti, and F. Parenti. 1990. In-vitro activity of vancomycin, teicoplanin, daptomycin, ramoplanin, MDL 62873 and other agents against staphylococci, enterococci, and Clostridium difficile. J. Antimicrob. Chemother. 26:627-633.
2. Biavasco, F., E. Manso, and P. E. Varaldo. 1991. In vitro activities of ramoplanin and four glycopeptide antibiotics against clinical isolates of Clostridium difficile. Antimicrob. Agents Chemother. 35:195-197.
3. Bonhoff, M., C. P. Miller, and W. R. Martin. 1964. Resistance of the mouse's intestinal tract to experimental Salmonella infection. II. Factors responsible for its loss following streptomycin treatment. J Exp. Med. 120:817-827.
4. Boyce, J. M., S. M. Opal, J. W. Chow, M. J. Zervos, G. Potter-Bynoe, C. B. Sherman, R. L. C. Romulo, S. Fortna, and A. A. Medeiros. 1994. Outbreak of multidrug-resistant Enterococcus faecium with transferable vanB class vancomycin resistance. J. Clin. Microbiol 32:1148-1153
5. Bush, L. M., J. Calmon, C. Cherney, M. Wendeler, P. Pitsakis, J. Poupard, M. E. Levison, and C. C. Johnson. 1989. High-level penicillin resistance among isolates of enterococci. Implications for treatment of serious enterococcal infections. Ann. Intern. Med. 110:515-520.
6. Centers for Disease Control and Prevention. 1995 Recommendations for preventing the spread of vancomycin-resistance - report from the hospital infection control practices advisory committee (HICPAC). Morbid. Mortal Weekly Rep. 44(RR-12):1-13
7. Edmund, M. B., J. F. Ober, D. L. Weinbaum, M. A. Pfaller, T. Hwang, M. D. Sanford, and R. P. Wenzel. 1995. Vancomycin-resistant Enterococcus faecium bacteremia: risk factors for infection. Clin Infect. Dis. 20:1126-1133.
8. Handwerger, S., B. Raucher, D. Altarac, J. Monka, S. Marchione, K. V. Singh, B. E. Murray, J. Wolff, and B. Walters. 1993. Nosocomial outbreak due to Enterococcus faecium highly resistant to vancomycin, penicillin, and gentamicin Clin. Infect. Dis. 16:750-755.
9. Herman, D. J., and D. N. Gerding. 1991. Screening and treatment of infections caused by resistant enterococci Antimicrob. Agents Chemother. 35: 215-219.
10. Johnson, C. C., S. Taylor, P. Pitsakis, P. May, and M. E. Levison. 1992. Bactericidal activity of ramoplanin against antibiotic-resistant enterococci. Antimicrob. Agents Chemother. 36:2342-2345.
11. Livornese, L. L., S. Dias, C. Samel, B. Romanowski, S. Taylor, P. Pitsakis, P. May, G. Woods, D. Kaye, M. E. Levison, and C. C. Johnson. 1992. Hospital-acquired infection with vancomycin-resistant Enterococcus faecium transmitted by electronic thermometers. Ann. Intern. Med. 117:112-116.
12. Maki, D. G., and W. A. Agger. 1988. Enterococcal bacteremia: clinical features, the risk of endocarditis, and management. Medicine 67:248-269.
13. Maple, P. A. C., J. M. T. Hamilton-Miller, and W. Brumfitt. 1989. Comparative in vitro activity of vancomycin, teicoplanin, ramoplanin (formerly A16686), paldimycin, DuP 721 and DuP 105 against methicillin and gentamicin resistant Staphylococcus aureus. J. Antimicrob. Chemother. 23:517-525.
14. Montecalvo, M. A., H. Horowitz, C. Gedris, C. Carbonaro, F. C. Tenover, A. Issah, P. Cook, and G. P. Wormser. 1994 Outbreak of vancomycin-, ampicillin-, and aminoglycoside-resistant Enterococcus faecium bacteremia in an adult oncology unit Antimicrob Agents Chemother. 38:1363-1367.
15. Montecalvo, M. A., H. Horowitz, G. B. Wormser, K. Seiter, and C. Carbonaro. 1995. Effect of novobiocin-containing antimicrobial regimens on infection and colonization with vancomycin-resistant Enterococcus faecium. Antimicrob. Agents Chemother 39:794
16. Morris, J. G., D. K. Shay, J. N. Hebden, R. J. McCarter, B. E. Perdue, W. Jarvis, J. A. Johnson, T. C. Dowling, L. B. Polish, and R. S. Schwalbe. 1995 Enterococci resistant to multiple antimicrobial agents, including vancomycin, establishment of endemicity in a university medical center. Ann. Intern. Med. 123:250-259.
17. Murray, B. E. 1990. The life and times of the enterococcus. Clin Microbiol. Rev. 3:46-65.
18. Murray, B. E. 1995 Editorial response: what can we do about vancomycin-resistant enterococcus? Clin. Infect. Dis. 20:1134-1136.
19. National Committee for Clinical Laboratory Standards. 1993. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 3rd ed. Approved standard M7-A3. National Committee for Clinical Laboratory Standards, Villanova, Pa.
20. O'Hare, M. D., D. Felmingham, and R. N. Gruneberg. 1989 In vitro bactericidal activity of the glycopeptide compounds vancomycin, teicoplanin, and ramoplanin (A-16686/MDL 62,198). Chemotherapy (Basel) 4(S4):210-211.
21. O'Hare, M. D., G. Ghosh, D. Felmingham, and R. N. Gruneberg. 1990. In-vitro studies with ramoplanin (MDL 62,198): a novel lipoglycopeptide antimicrobial. J. Antimicrob. Chemother. 25:217-220.
22. Pearson, R. D., R. T. Steigbigel, H. T. Davis, and S. W. Chapman. 1980. Method for reliable determination of minimal lethal antibiotic concentrations. Antimicrob. Agents Chemother. 18:699-708
23. Rhinehart, E., N. E. Smith, C. Wennerstein, E. Gorss, J. Freeman, G. M. Eliopoulos, R. C. Moellering, and D. A. Goldman. 1990. Rapid dissemination of beta-lactamase-producing, aminoglycoside-resistant Enterococcus faecalis among patients and staff on an infant-toddler surgical ward. N. Engl. J Med 323:1814-1818.
24. Somner, E. A., and P. E. Reynolds. 1990. Inhibition of peptidoglycan biosynthesis by ramoplanin. Antimicrob. Agents Chemother. 34:413-419
25. Vollard, E. J., and H. A. L. Clasner. 1994 Colonization resistance. Antimicrob. Agents Chemother. 38:409-414.
26. Wells, C., B. A. Juni, S. B. Cameron, K. R. Mason, D. L. Dunn, P. Ferrieri, and F. S. Rhame. 1995. Stool carriage, clinical isolation, and mortality during an outbreak of vancomycin-resistant enterococci in hospitalized medical and/or surgical patients. Clin. Infect. Dis. 21:45-50.
27. Zervos, M. F., C. A. Kauffman, P. M. Therasse, A. G. Bergman, T. S. Mikesell, and D. R. Schaberg. 1987. Nosocomial infection by gentamicin-resistant Streptococcus faecalis: an epidemiologic study Ann. Intern. Med 106:687-691